
--- Page 1 ---
PATIeNt hISTory: CHIEF COMPLAINT/ PRE-OP/ POST-OP DIAGNOSIS: Loft bresst invasrve ductal carcinoma.e LMP DATE NoI applicable PROCEOURE Lot segmental mastectomy with sentine! lymph node blopsy. Jcs-0-3 SPECIFIC CLINICAL QUESTION: Not Itsted. OUTSIDE TISSUE DIAGNOSIS: Not listed Carmimr,nif1truting chuch! nos 850c/3 PRIOR MALIGNANCY. Not listed. CHEMORADIATION THERAPY: Not Ilsted SiFu.5ust,nrs c5u 9 h 3f28/1 OTHER DISEASFS Nol listed FINAL DIAGNOSIS: Part 1: Lymph node. non-sentnel. Biopsy -- . . One (1) Lymph node, negative.fOr metastatic.carcinoma (0v1).. . PArt 2: Lymph node, LEft axILLA, Sentinel #1, BIOpSy -- ONe (1) LyMPh nODE. NEgATIVE fOR METASTATIC CARcINOmA (0/1). Part 3: Lymph nOde, LEft AXILLA, SEntinel #2, BiOpsy - One (1) Lymph nOde. negative fOr metastATiC Carcinoma (0/1) Part 4: Breast, Left, Segmental mastectomy --  InyaSiye Ductal carcinoma, no special type. 4 NOttinghAm GrADe in (TUBuLe fOrmATiOn: 3, nUcleaR PleOmOrphIsm: 3, miTOtic AcTtmiTy: 3; TOTAL SCORE: 9/9). The invAsive Tumor neasures 2.6 Cm in LArgest DimensiON. D. Ductal. carcinoma in situ, nuclear grade 3, solib type with comedo necrosis. E The DuctAL CArcinomA in SiTu COnstITutEs 40% OF The TOtAL TUmOr vOLUme And is PREsEnte Admixe? with the invasive component. F No' lymphovascular space invasion is noted. G.  Resection margins are negative for carcinoma.  invasive carcinoma is o.4 cm From the nearest (Anterior) margin. Ductal CarcinOma in srtU is 0.3 Cm FRom the neArest (AnterIoR) mArgin.e Atypical Ductal hyperplasia. K THE non-neoplasTic Breast shows DuctAL epiTheLial hyperplasiA, intraductAl Papilloma, Radial scar, columnar cell. Changes, and fibrocystic Changes. PREVIOUS BIOPSY SITE CHANGES. Part 5: Lymph noDe, Left "Intramammary", Excisional siOpsy -- One (1) LyMPh nOde, nEgatIive fOr MetastATic.cArcinoma (01). B.  BENIGN PERINODAL ADIPOSE TISSUE.  No ouctal breast tissue seen. COmment: Part 4: The invasive tumor was reported to be positive for Eatrogen Roceptora (H-ecore; 250), positive for Progesterone Receptors (H-score: 75) and aiso positve for HER2, ss per previous pathology report (** CASE SYNOPSIS:  SyNOptic - PRImARy INVAsive CArciNomA Of BreAST LATERALITY: Lef! PROCEDURE: Segmental LOCATION: Clock positlon.12 SiZE OF TUmOR: Maximum dimension invasive component: 26 mm MULTICENTRICiTY/MuLTIFOCALITY OF INVASivE FOCi:E No TUMOR TYPE (invasive component): Ductel adenocarangma, NOS NOTTINGHAm SCORE:E Nudeer grade: 3 Tubule formation: 3 UUID:57323AES-3EFE-4492-8522-D9A6D83F1BE0  Redacted Mitotic activity score: 3 TCGA-BH-A202-01A-PR Total Nottingham score: 9. Nottingham grade (1. 2. 3): 3 ANGIOLYMPHATiC INVASION: No DeRmAl LymphATic inVaSION: Not applicable CALCIFICATION: No Tumor type, in situ: Solid Comedo  SURgICAl. MARGINS InVOLVED ay inVASIvE COMPOnEnt: No Distance of invasive tumor to closest margin: 4 mm Surg nargins involved by in situ component: No Distance of in situ disesse to closest margin: 3 mm LYMPH NODES POSITIVE; 0 LyMPH NODES EXAMINED: 4 mEThOD(S) Of LymPh nODE ExAmnAtION: H/E stain SENTINEL NODE METASTASIS: NON-NEOPLASTiC BREAST TISSUE: Radial scar, PapiHoma, FCD No T stage, pathologic: pT2 N STAGE mODIFIER: (sn) N stage, pathologic: pNO m stage: Not appicable ESTROGEN RECEPTORS: postive, H-score 250 PROGESTERONE RECEPTORS: positive, H-score: 75 HER2INEU: 3+ HIPA